A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)
Clinical trial NCT05764161 · COMPLETED
Trial details
- NCT number
- NCT05764161
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-12
- Primary completion
- 2024-12-30
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.